Reuters logo
BRIEF-Biocept presents analytical validation study results for PD-l1 liquid biopsy test
December 7, 2016 / 2:55 PM / 10 months ago

BRIEF-Biocept presents analytical validation study results for PD-l1 liquid biopsy test

Dec 7 (Reuters) - Biocept Inc:

* Biocept presents robust analytical validation study results for its PD-l1 liquid biopsy test

* Biocept-Further clinical testing showed ability of Co’s PD-l1 assay to successfully determine PD-l1 status on circulating tumor cells of clinical samples

* Biocept - study results yielded 100% concordance between PD-l1 expression of tumor cells and their original PD-l1 status, whether positive or negative Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below